B-ENT

ENT indications for Hyperbaric Oxygen Therapy

1.

Centre for Hyperbaric Oxygen Therapy, Military Hospital, Brussels, Belgium

2.

Department of Otorhinolaryngology and Head & Neck Surgery, St-Anne St-Remi Hospital (Chirec Group), Brussels, Belgium

3.

Department of Otorhinolaryngology and Head & Neck Surgery, Edith Cavell Hospital (Chirec Group), Brussels, Belgium

4.

Centre for Hyperbaric Oxygen Therapy, Military Hospital Brussels, Belgium

B-ENT 2016; 12: Supplement 87-106
Read: 935 Downloads: 632 Published: 03 February 2020

ENT indications for Hyperbaric Oxygen Therapy. Hyperbaric Oxygen (HBO) therapy is a treatment where patients breathe 100% oxygen while exposed to high environmental pressure in a hyperbaric chamber. This hyperoxygenation has several beneficial effects as an adjunctive treatment in a number of ENT-related conditions and diseases. These can be summarized as anti-ischaemic effects (delivery of oxygen to otherwise ischaemic tissues, reduction of ischaemia-reperfusion damage), anti-infectious effects (bacteriostasis, improved leucocyte phagocytosis bactericidal activity and optimization of antibiotic therapy) and wound-healing effects (stimulation of granulation tissue formation and stabilization).

Since HBO therapy has a clear physiologic rationale, a demonstrated effect (although difficult to “prove” with placebocontrolled randomized trials) in certain indications and certain side-effects, it is proposed that it should be considered an integral part of the (combined surgical and pharmacological) treatment of patients, and not simply as a supplementation of oxygen. Furthermore, the importance of a well-trained medical and technical staff to ensure proper selection and the correct follow-up of patients should not be underestimated.

Files
EISSN 2684-4907